Correlation Between 23Andme Holding and Entero Therapeutics,
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and Entero Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and Entero Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and Entero Therapeutics,, you can compare the effects of market volatilities on 23Andme Holding and Entero Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of Entero Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and Entero Therapeutics,.
Diversification Opportunities for 23Andme Holding and Entero Therapeutics,
-0.62 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between 23Andme and Entero is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and Entero Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entero Therapeutics, and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with Entero Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entero Therapeutics, has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and Entero Therapeutics, go up and down completely randomly.
Pair Corralation between 23Andme Holding and Entero Therapeutics,
Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to under-perform the Entero Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, 23Andme Holding Co is 1.7 times less risky than Entero Therapeutics,. The stock trades about -0.08 of its potential returns per unit of risk. The Entero Therapeutics, is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 460.00 in Entero Therapeutics, on August 24, 2024 and sell it today you would lose (418.00) from holding Entero Therapeutics, or give up 90.87% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
23Andme Holding Co vs. Entero Therapeutics,
Performance |
| Timeline |
| 23Andme Holding |
| Entero Therapeutics, |
23Andme Holding and Entero Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 23Andme Holding and Entero Therapeutics,
The main advantage of trading using opposite 23Andme Holding and Entero Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, Entero Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entero Therapeutics, will offset losses from the drop in Entero Therapeutics,'s long position.| 23Andme Holding vs. IDEXX Laboratories | 23Andme Holding vs. Twist Bioscience Corp | 23Andme Holding vs. Guardant Health | 23Andme Holding vs. Agilent Technologies |
| Entero Therapeutics, vs. CapitaLand Investment Limited | Entero Therapeutics, vs. Fidus Investment Corp | Entero Therapeutics, vs. Aldel Financial II | Entero Therapeutics, vs. SEI Investments |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |